Thomas Wakim
Stock Analyst at Bell Potter
(0.11)
# 4,432
Out of 4,501 analysts
100
Total ratings
38.2%
Success rate
-15.9%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.20 → $3.70 | $2.90 | +27.59% | 6 | Jul 8, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.06 | $0.023 | +160.87% | 6 | Jul 7, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $22.00 → $23.50 | $16.52 | +42.25% | 15 | Jun 29, 2026 | |
| ASX: ALC Alcidion Group Limited | Maintained: Buy | $0.16 | $0.098 | +63.27% | 13 | May 25, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $19.00 → $17.00 | $10.27 | +65.53% | 5 | May 24, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $155.00 → $100.00 | $122.89 | -18.63% | 9 | May 11, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Maintained: Buy | $0.13 → $0.12 | $0.041 | +192.68% | 12 | May 1, 2026 | |
| ASX: GSS Genetic Signatures Limited | Downgraded: Hold | $0.55 → $0.10 | $0.064 | +56.25% | 8 | Apr 7, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.30 | $1.56 | +47.91% | 7 | Mar 17, 2026 | |
| ASX: IMM Immutep Limited | Downgraded: Hold | $0.65 → $0.07 | $0.051 | +37.25% | 8 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.42 | $0.145 | +189.66% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.09 → $0.10 | $0.017 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.012 | n/a | 4 | Apr 1, 2025 |
Cogstate Limited
Jul 8, 2026
Maintained: Buy
Price Target: $3.20 → $3.70
Current: $2.90
Upside: +27.59%
Syntara Limited
Jul 7, 2026
Maintained: Buy
Price Target: $0.06
Current: $0.023
Upside: +160.87%
Neuren Pharmaceuticals Limited
Jun 29, 2026
Maintained: Buy
Price Target: $22.00 → $23.50
Current: $16.52
Upside: +42.25%
Alcidion Group Limited
May 25, 2026
Maintained: Buy
Price Target: $0.16
Current: $0.098
Upside: +63.27%
Clinuvel Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $19.00 → $17.00
Current: $10.27
Upside: +65.53%
CSL Limited
May 11, 2026
Maintained: Hold
Price Target: $155.00 → $100.00
Current: $122.89
Upside: -18.63%
Microba Life Sciences Limited
May 1, 2026
Maintained: Buy
Price Target: $0.13 → $0.12
Current: $0.041
Upside: +192.68%
Genetic Signatures Limited
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.064
Upside: +56.25%
PYC Therapeutics Limited
Mar 17, 2026
Maintained: Buy
Price Target: $2.30
Current: $1.56
Upside: +47.91%
Immutep Limited
Mar 16, 2026
Downgraded: Hold
Price Target: $0.65 → $0.07
Current: $0.051
Upside: +37.25%
Aug 7, 2025
Maintained: Buy
Price Target: $0.42
Current: $0.145
Upside: +189.66%
May 13, 2025
Maintained: Hold
Price Target: $0.09 → $0.10
Current: $0.017
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.012
Upside: n/a